Septerna - Crunchbase Company Profile & Funding

Q: Who invested in Septerna?

Septerna has 15 investors including Vertex Ventures HC And Soleus Capital.

Q: When was the last funding round for Septerna?

Septerna closed its last funding round on obfuscated from a Series B round.

Q: How much funding has Septerna raised to date?

Septerna has raised obfuscated.

Overview

Septerna

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Septerna

CB Rank

7552

Septerna is a biotech firm unlocking diverse drug discovery potential in G protein-coupled receptors across various diseases.

Acquired by

Vertex Pharmaceuticals

Founded

obfuscation

Public

Series B

San Francisco, California, United States

51-100

septerna.com

Biotechnology

Information Technology

Medical

Software

Funding Rounds

Series B

OBF

obfuscation

Series A

OBF

obfuscation

Key People

Jeffrey Finer: Co-Founder and Chief Executive Officer
Past Role: Ambys Medicines, Interim Chief Technology Officer
Patrick Sexton: Co-Founder

Details

Legal Name

Septerna, Inc.

Operating Status

Active

Stock Symbol

NASDAQ:SEPN

Company Type

For Profit

Founders

Arthur Christopoulos, Jeffrey Finer, Patrick Sexton, Robert Lefkowitz

About the Company

Septerna is a biotechnology company that discovers and advances novel small-molecule medicines targeting G protein-coupled receptors. The company's mission is to discover, develop, and commercialize medicines that improve the lives of patients by combining GPCR drug targets with the power of state-of-the-art small molecule drug discovery

technologies. Septerna’s Native Complex platform is the engine that will make this happen.

Phone Number

650-338-3533

Contact Email

Info@septerna.com

Predictions & Insights

Growth Insight

See this Growth Insight

Septerna is

Lorem

to be growing

Top Contributing Factors

Financial Growth

Products & Services

Native Complex Platform™

An industrial-scale platform for discovering and developing oral small molecule drugs targeting G protein-coupled receptors (GPCRs).

PTH1R Program Agonist

An oral small molecule agonist targeting the parathyroid hormone 1 receptor (PTH1R) for treating hypoparathyroidism.

Research & Development

Septerna is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series B - Septerna	15	obfuscated obfuscation	RA Capital Management	Series B
obfuscated obfuscation	Series B - Septerna	15	obfuscated obfuscation	RA Capital Management	Series B
obfuscated obfuscation	Series B - Septerna	15	obfuscated obfuscation	RA Capital Management	Series B
obfuscated obfuscation	Series B - Septerna	15	obfuscated obfuscation	RA Capital Management	Series B
obfuscated obfuscation	Series B - Septerna	15	obfuscated obfuscation	RA Capital Management	Series B

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series B - Septerna	15	obfuscated obfuscation	RA Capital Management	Series B
obfuscated obfuscation	Series B - Septerna	15	obfuscated obfuscation	RA Capital Management	Series B
obfuscated obfuscation	Series B - Septerna	15	obfuscated obfuscation	RA Capital Management	Series B
obfuscated obfuscation	Series B - Septerna	15	obfuscated obfuscation	RA Capital Management	Series B
obfuscated obfuscation	Series B - Septerna	15	obfuscated obfuscation	RA Capital Management	Series B

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Vertex Ventures HC	—	Series B - Septerna	—
Vertex Ventures HC	—	Series B - Septerna	—
Vertex Ventures HC	—	Series B - Septerna	—
Vertex Ventures HC	—	Series B - Septerna	—
Vertex Ventures HC	—	Series B - Septerna	—